• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Surgical significance of telomerase activity in noncancerous liver tissue from patients with hepatocellular carcinoma.肝细胞癌患者非癌性肝组织中端粒酶活性的手术意义
Jpn J Cancer Res. 1998 Jul;89(7):727-32. doi: 10.1111/j.1349-7006.1998.tb03277.x.
2
Clinical implications of telomerase activity in resected hepatocellular carcinoma.
Int J Mol Med. 1999 Sep;4(3):267-71.
3
Clinical significance of telomerase activity in hepatocellular carcinoma.
Kobe J Med Sci. 1996 Jun;42(3):207-17.
4
Telomerase activity in hepatocellular carcinoma as a predictor of postoperative recurrence.
J Gastroenterol. 1997 Dec;32(6):791-6. doi: 10.1007/BF02936956.
5
Dedifferentiation of human hepatocellular carcinoma up-regulates telomerase and Ki-67 expression.人肝细胞癌的去分化上调端粒酶和Ki-67表达。
Arch Surg. 2000 Nov;135(11):1334-9. doi: 10.1001/archsurg.135.11.1334.
6
Relationship between microvessel density and telomerase activity in hepatocellular carcinoma.肝细胞癌中微血管密度与端粒酶活性的关系
World J Gastroenterol. 2004 Jul 15;10(14):2147-9. doi: 10.3748/wjg.v10.i14.2147.
7
Telomerase activity in precancerous hepatic nodules.癌前肝结节中的端粒酶活性。
Cancer. 1998 May 15;82(10):1831-8.
8
[Telomerase activity in liver cancer and the adjacent tissue].[肝癌及癌旁组织中的端粒酶活性]
Zhonghua Zhong Liu Za Zhi. 1998 Nov;20(6):434-6.
9
Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma.端粒酶逆转录酶mRNA在肝细胞癌中的表达及端粒酶活性
J Gastroenterol. 1999 Feb;34(1):83-7. doi: 10.1007/s005350050220.
10
[Study on telomerase activity in hepatocellular carcinoma and chronic hepatitic disease].
Zhonghua Bing Li Xue Za Zhi. 1998 Apr;27(2):91-3.

本文引用的文献

1
Telomerase activity in hepatocellular carcinoma as a predictor of postoperative recurrence.
J Gastroenterol. 1997 Dec;32(6):791-6. doi: 10.1007/BF02936956.
2
hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.hEST2,即假定的人类端粒酶催化亚基基因,在肿瘤细胞和永生化过程中上调。
Cell. 1997 Aug 22;90(4):785-95. doi: 10.1016/s0092-8674(00)80538-3.
3
A survey of telomerase activity in human cancer.一项关于人类癌症中端粒酶活性的调查。
Eur J Cancer. 1997 Apr;33(5):787-91. doi: 10.1016/S0959-8049(97)00062-2.
4
Telomerase catalytic subunit homologs from fission yeast and human.来自裂殖酵母和人类的端粒酶催化亚基同源物。
Science. 1997 Aug 15;277(5328):955-9. doi: 10.1126/science.277.5328.955.
5
Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma.端粒酶活性在小分化型肝细胞癌诊断中的意义
Int J Cancer. 1997 Apr 22;74(2):141-7. doi: 10.1002/(sici)1097-0215(19970422)74:2<141::aid-ijc1>3.0.co;2-z.
6
Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.肝细胞癌发生过程中的端粒进行性缩短和端粒酶重新激活。
Cancer Genet Cytogenet. 1997 Jan;93(1):56-62. doi: 10.1016/s0165-4608(96)00329-9.
7
Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease.肝细胞癌和慢性肝病中的端粒酶活性与端粒长度
Gastroenterology. 1997 Feb;112(2):493-500. doi: 10.1053/gast.1997.v112.pm9024303.
8
Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma.
Cancer. 1996 Jul 15;78(2):232-36. doi: 10.1002/(SICI)1097-0142(19960715)78:2<232::AID-CNCR7>3.0.CO;2-N.
9
Telomere changes in human hepatocellular carcinomas and hepatitis virus infected noncancerous livers.人类肝细胞癌及肝炎病毒感染的非癌肝脏中的端粒变化。
Cancer. 1996 Apr 15;77(8 Suppl):1747-51. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1747::AID-CNCR50>3.0.CO;2-W.
10
Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.人类肝脏组织中的端粒酶活性:慢性肝病与肝细胞癌的比较
Cancer Res. 1995 Jul 1;55(13):2734-6.

肝细胞癌患者非癌性肝组织中端粒酶活性的手术意义

Surgical significance of telomerase activity in noncancerous liver tissue from patients with hepatocellular carcinoma.

作者信息

Kanamaru T, Morita Y, Itoh T, Yamamoto M, Kuroda Y, Hisatomi H

机构信息

First Department of Surgery, Kobe University School of Medicine.

出版信息

Jpn J Cancer Res. 1998 Jul;89(7):727-32. doi: 10.1111/j.1349-7006.1998.tb03277.x.

DOI:10.1111/j.1349-7006.1998.tb03277.x
PMID:9738979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5921885/
Abstract

Telomerase activity has been detected in tissue from noncancerous liver of patients with chronic liver disease, but its functional significance remains to be elucidated. We therefore evaluated the telomerase activity in surgically obtained noncancerous liver tissue from 20 hepatocellular carcinoma (HCC) patients. Two samples of noncancerous liver tissue were obtained from each patient: one from the parenchyma adjacent to the HCC nodules of the resected specimen; the other from the parenchyma distant from the HCC nodules of the remnant liver. Telomerase activity was assayed by a non-radioisotope quantitative system based on "TRAP-eze." Five samples from the noncancerous liver tissue adjacent to the HCC nodules (25.0%) were telomerase-positive; all such cases showed high-grade malignant potential, such as intrahepatic metastasis and/or portal vascular invasion and infiltration of the fibrous capsule in the corresponding HCC nodules, and telomerase positivity showed neither a relationship with the histological activity index scores nor a correlation with liver function. Interestingly, no telomerase activity was detected in any of the 20 samples obtained from the parenchyma of the remnant liver. These results indicate that telomerase in noncancerous liver tissue is associated not with the hepatic condition accompanying HCC, but with the biological characteristics of the tumor itself, and may derive from infiltrating cancer cells. Determination of telomerase status may aid in designing more effective surgical procedures.

摘要

在慢性肝病患者的非癌性肝组织中已检测到端粒酶活性,但其功能意义仍有待阐明。因此,我们评估了20例肝细胞癌(HCC)患者手术获取的非癌性肝组织中的端粒酶活性。从每位患者获取两份非癌性肝组织样本:一份来自切除标本中与HCC结节相邻的实质;另一份来自残余肝中远离HCC结节的实质。采用基于“TRAP-eze”的非放射性同位素定量系统检测端粒酶活性。与HCC结节相邻的非癌性肝组织中有5份样本(25.0%)端粒酶呈阳性;所有这些病例均显示出高恶性潜能,如肝内转移和/或门静脉血管侵犯以及相应HCC结节中纤维包膜的浸润,并且端粒酶阳性与组织学活性指数评分无关,也与肝功能无关。有趣的是,从残余肝实质获取的20份样本中均未检测到端粒酶活性。这些结果表明,非癌性肝组织中的端粒酶并非与HCC伴发的肝脏状况相关,而是与肿瘤本身的生物学特性相关,并且可能来源于浸润的癌细胞。端粒酶状态的测定可能有助于设计更有效的手术方案。